Stockreport

BRIEF-BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine [Reuters]

BiondVax Pharmaceuticals Ltd. - American Depositary Shares  (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
PDF BRIEF-BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine | Reuters Reuters Staff 1 Min Read Nov 20 (Reuters) - Biondvax Pharmaceu [Read more]